INOGEN, INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 6.78 USD | +4.63% |
|
+0.44% | +23.50% |
| Feb. 28 | Top Midday Decliners | MT |
| Feb. 28 | Top Premarket Decliners | MT |
Valuation
| Fiscal Period: December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|
| Capitalization 1 | 1,503 | 988.2 | 772.6 | 451.8 | 128 | 159.6 | - | - |
| Enterprise Value (EV) 1 | 1,305 | 776.3 | 537.1 | 264.8 | -0.5111 | 80.73 | 105.2 | 127.1 |
| P/E ratio | 72.7 x | -165 x | -121 x | -5.37 x | -1.24 x | -2.71 x | -3.47 x | -3.73 x |
| Yield | - | - | - | - | - | - | - | - |
| Capitalization / Revenue | 4.15 x | 3.2 x | 2.16 x | 1.2 x | 0.41 x | 0.49 x | 0.47 x | 0.45 x |
| EV / Revenue | 3.61 x | 2.52 x | 1.5 x | 0.7 x | -0 x | 0.25 x | 0.31 x | 0.35 x |
| EV / EBITDA | 30.1 x | 35.9 x | 18.2 x | -19.6 x | 0.01 x | -2.91 x | -4.52 x | -9.49 x |
| EV / FCF | 38 x | 39.5 x | -1,778 x | -4.51 x | 0.02 x | - | -3.9 x | -5.3 x |
| FCF Yield | 2.63% | 2.53% | -0.06% | -22.2% | 5,821% | - | -25.7% | -18.9% |
| Price to Book | 4.37 x | 2.83 x | 2.09 x | 1.52 x | 0.63 x | 0.9 x | 0.94 x | 0.92 x |
| Nbr of stocks (in thousands) | 21,998 | 22,118 | 22,724 | 22,921 | 23,308 | 23,547 | - | - |
| Reference price 2 | 68.33 | 44.68 | 34.00 | 19.71 | 5.490 | 6.780 | 6.780 | 6.780 |
| Announcement Date | 2/25/20 | 2/24/21 | 2/24/22 | 2/23/23 | 2/27/24 | - | - | - |
1USD in Million2USD
Estimates
Income Statement Evolution (Annual data)
| Fiscal Period: December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|
| Net sales 1 | 361.9 | 308.5 | 358 | 377.2 | 315.7 | 323.6 | 338.5 | 358.2 |
| EBITDA 1 | 43.33 | 21.65 | 29.5 | -13.53 | -37.78 | -27.7 | -23.27 | -13.4 |
| EBIT 1 | 19.79 | -12.02 | 9.24 | -33.08 | -109.4 | -60.75 | -53.95 | -39.9 |
| Operating Margin | 5.47% | -3.9% | 2.58% | -8.77% | -34.65% | -18.77% | -15.94% | -11.14% |
| Earnings before Tax (EBT) 1 | 24.27 | -5.28 | 8.659 | -83.27 | -102.3 | -58.26 | -52.02 | -45.19 |
| Net income 1 | 20.95 | -5.829 | -6.333 | -83.77 | -102.4 | -57.86 | -51.65 | -45.19 |
| Net margin | 5.79% | -1.89% | -1.77% | -22.21% | -32.46% | -17.88% | -15.26% | -12.61% |
| EPS 2 | 0.9400 | -0.2700 | -0.2800 | -3.670 | -4.420 | -2.498 | -1.954 | -1.818 |
| Free Cash Flow 1 | 34.33 | 19.67 | -0.302 | -58.75 | -29.75 | - | -27 | -24 |
| FCF margin | 9.49% | 6.38% | -0.08% | -15.57% | -9.43% | - | -7.98% | -6.7% |
| FCF Conversion (EBITDA) | 79.23% | 90.87% | - | - | - | - | - | - |
| FCF Conversion (Net income) | 163.88% | - | - | - | - | - | - | - |
| Dividend per Share | - | - | - | - | - | - | - | - |
| Announcement Date | 2/25/20 | 2/24/21 | 2/24/22 | 2/23/23 | 2/27/24 | - | - | - |
1USD in Million2USD
Estimates
Income Statement Evolution (Quarterly data)
| Fiscal Period: December | 2021 Q3 | 2021 Q4 | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 | 2025 Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net sales 1 | 93.1 | 76.4 | 80.38 | 103.4 | 105.4 | 88.09 | 72.16 | 83.64 | 83.97 | 75.9 | 73.68 | 84.18 | 85.5 | 80.35 | 78.2 |
| EBITDA 1 | 12.17 | -0.475 | -4.964 | 3.229 | -1.164 | -10.63 | -11.79 | -3.192 | -5.456 | -17.35 | -9.867 | -5.7 | -4.967 | -7.267 | - |
| EBIT 1 | 6.374 | -6.673 | -13.59 | -2.876 | -10.29 | -6.328 | -21.92 | -11.77 | -46.72 | -28.98 | -19.1 | -13.3 | -12.2 | -16.15 | - |
| Operating Margin | 6.85% | -8.73% | -16.9% | -2.78% | -9.77% | -7.18% | -30.37% | -14.07% | -55.64% | -38.19% | -25.92% | -15.8% | -14.27% | -20.1% | - |
| Earnings before Tax (EBT) 1 | 5.929 | -6.889 | -13.99 | -3.373 | -9.436 | -56.47 | -20.15 | -9.785 | -45.32 | -27.09 | -17.1 | -13.57 | -12.87 | -14.8 | - |
| Net income 1 | 12.17 | -22.88 | -14.21 | -3.442 | -9.506 | -56.61 | -20.35 | -9.826 | -45.72 | -26.56 | -17 | -13.5 | -12.8 | -14.7 | - |
| Net margin | 13.08% | -29.94% | -17.68% | -3.33% | -9.02% | -64.26% | -28.2% | -11.75% | -54.45% | -34.99% | -23.07% | -16.04% | -14.97% | -18.29% | - |
| EPS 2 | 0.5300 | -1.010 | -0.6200 | -0.1500 | -0.4200 | -2.470 | -0.8800 | -0.4200 | -1.970 | -1.140 | -0.7568 | -0.6016 | -0.5367 | -0.6002 | -0.5600 |
| Dividend per Share | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Announcement Date | 11/4/21 | 2/24/22 | 5/5/22 | 8/4/22 | 11/2/22 | 2/23/23 | 5/4/23 | 8/7/23 | 11/7/23 | 2/27/24 | - | - | - | - | - |
1USD in Million2USD
Estimates
Balance Sheet Analysis
| Fiscal Period: December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|
| Net Debt 1 | - | - | - | - | - | - | - | - |
| Net Cash position 1 | 198 | 212 | 236 | 187 | 128 | 78.9 | 54.5 | 32.5 |
| Leverage (Debt/EBITDA) | - | - | - | - | - | - | - | - |
| Free Cash Flow 1 | 34.3 | 19.7 | -0.3 | -58.8 | -29.8 | - | -27 | -24 |
| ROE (net income / shareholders' equity) | 6.4% | -1.68% | -1.76% | -9.47% | -40.8% | -30.9% | -31.4% | -28.5% |
| ROA (Net income/ Total Assets) | 5.09% | -1.28% | -1.33% | -7.07% | -28% | -18.8% | -18% | -16% |
| Assets 1 | 411.6 | 454.6 | 475.8 | 1,185 | 365.6 | 307.1 | 286.8 | 281.7 |
| Book Value Per Share 2 | 15.60 | 15.80 | 16.30 | 13.00 | 8.780 | 7.500 | 7.240 | 7.360 |
| Cash Flow per Share | - | - | - | - | - | - | - | - |
| Capex 1 | 6.26 | 17.3 | 23.9 | 21.2 | 26.5 | 31 | 37 | 44 |
| Capex / Sales | 1.73% | 5.62% | 6.69% | 5.63% | 8.4% | 9.58% | 10.93% | 12.28% |
| Announcement Date | 2/25/20 | 2/24/21 | 2/24/22 | 2/23/23 | 2/27/24 | - | - | - |
1USD in Million2USD
Estimates
EPS & Dividend
Year-on-year evolution of the PER
Change in Enterprise Value/EBITDA
Trading Rating
Investor Rating
ESG Refinitiv
B
Sell
Buy
Mean consensus
HOLD
Number of Analysts
4
Last Close Price
6.78
USD
Average target price
6.5
USD
Spread / Average Target
-4.13%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| +23.50% | 160M | |
| -2.31% | 187B | |
| -3.20% | 106B | |
| -5.04% | 66.9B | |
| +0.20% | 49.45B | |
| +17.29% | 48B | |
| +4.06% | 40.84B | |
| +2.07% | 26.48B | |
| +2.36% | 26.25B | |
| +12.96% | 24.62B |
- Stock Market
- Equities
- INGN Stock
- Financials Inogen, Inc.
